Back to All Solutions
Request a Sample
maqui bright logo
Support dry eye relief

BrightMaqui®

MaquiBright® is a patented premium maqui berry extract extraordinarily rich in flavonoids. It is standardized to contain at least 25 % delphinidins and a minimum of 35 % total anthocyanins.

Maqui berry is a native berry that grows in Chile and has been consumed since ancient times. It is extraordinarily rich in many nutrients and powerful flavonoid species known as anthocyanins. A specific category of these flavonoids, known as delphinidins, are responsible for the very dark purple color of the berries as well as for several health benefits.

Key Facts
  • Scientifically proven ingredient based on several clinical and in vitro studies.
  • Has shown a significant increase in tear production by 89% after 4 weeks.
  • Reported a significant reduction of 57% in bothersome ocular discomfort after 4 weeks.
  • Supports eye health with its high antioxidant and anthocyanin content.*
  • Helps nourish the eyes and naturally restores normal tear production.*
  • Potent antioxidant that supports the eyes’ response to oxidative stress.*
  • Relieves eye fatigue, shoulder stiffness, and temporary eye discomfort from prolonged screen use.**
*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.
*** Authorised by Ministry of Health, Labour, and Welfare, Japan

Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light; J. Tanaka et al; Chem. 2013 Aug 15;139(1-4):129-37. doi 10.1016/j.foodchem.2013.01.036. Epub 2013 Jan 29.

Delphinidin 3,5-O-diglucoside, a constituent of the maqui berry (Aristotelia chilensis) anthocyanin, restores tear secretion in a rat dry eye model; S. Nakamura et al.; Journal of Functional Foods, Volume 10, September 2014, Pages 346-354
MaquiBright™ standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial; Hitoe et al.; Panminerva Med. 2014 Sep;56(3 Suppl 1):1-6.
Effects of MaquiBright on Improving Eye Dryness and Fatigue in Humans: A Randomized, Double-blind, Placebo-controlled Trial”; The Journal of Traditional and Complementary Medicine; Yamashita et al., 2018
Delphinidins from Maqui Berry (Aristotelia chilensis) ameliorate the subcellular organelle damage induced by blue light exposure in murine photoreceptor-derived cells; Yamazaki et al; MC Complement Med Ther. 2024 Jan 2;24(1):3. doi: 10.1186/s12906-023-04322-z.
phytonet awards
  • 2019 NutraIngredient Award Wiiner – Product of the Year: OptiBright by Anklam Extract
  • Scientifically proven ingredient based on several clinical and in vitro studies.
  • Has shown a significant increase in tear production by 89% after 4 weeks.
  • Reported a significant reduction of 57% in bothersome ocular discomfort after 4 weeks.
  • Supports eye health with its high antioxidant and anthocyanin content.*
  • Helps nourish the eyes and naturally restores normal tear production.*
  • Potent antioxidant that supports the eyes’ response to oxidative stress.*
  • Relieves eye fatigue, shoulder stiffness, and temporary eye discomfort from prolonged screen use.**
*These statements have not been evaluated by the US Food & Drug Administration or the European Food and Safety Authority. This product is not intended to diagnose, treat, cure, or prevent any disease.
*** Authorised by Ministry of Health, Labour, and Welfare, Japan

Maqui berry (Aristotelia chilensis) and the constituent delphinidin glycoside inhibit photoreceptor cell death induced by visible light; J. Tanaka et al; Chem. 2013 Aug 15;139(1-4):129-37. doi 10.1016/j.foodchem.2013.01.036. Epub 2013 Jan 29.

Delphinidin 3,5-O-diglucoside, a constituent of the maqui berry (Aristotelia chilensis) anthocyanin, restores tear secretion in a rat dry eye model; S. Nakamura et al.; Journal of Functional Foods, Volume 10, September 2014, Pages 346-354
MaquiBright™ standardized maqui berry extract significantly increases tear fluid production and ameliorates dry eye-related symptoms in a clinical pilot trial; Hitoe et al.; Panminerva Med. 2014 Sep;56(3 Suppl 1):1-6.
Effects of MaquiBright on Improving Eye Dryness and Fatigue in Humans: A Randomized, Double-blind, Placebo-controlled Trial”; The Journal of Traditional and Complementary Medicine; Yamashita et al., 2018
Delphinidins from Maqui Berry (Aristotelia chilensis) ameliorate the subcellular organelle damage induced by blue light exposure in murine photoreceptor-derived cells; Yamazaki et al; MC Complement Med Ther. 2024 Jan 2;24(1):3. doi: 10.1186/s12906-023-04322-z.
phytonet awards
  • 2019 NutraIngredient Award Wiiner – Product of the Year: OptiBright by Anklam Extract

Health Indications

General Wellbeing

To support overall health and complement the diet.

Eye Health

To maintain vision and eye health.

Antioxidant Support

To combat oxidative stress.
Back to All Solutions

Applications

MaquiBright® is a highly soluble extract that has demonstrated significant clinical benefits at low doses.

It can be used alone or in combination with other ingredients in supplements aimed at promoting eye health.

Go to Applications
phytonet favicon

Ready to realize your product’s full potential?

We work closely with our customers and our world-wide suppliers to source and scientifically back innovative ingredients for your product development needs.
contact us now
phytonet white logo

Transforming Your Ideas into Market-Ready Solutions

Contact us:

  • Untere Paulistrasse 51,
    8834 Schindellegi-Feusisberg, Switzerland
  • info@phytonet.com
  • +41 43 477 94 75

Sitemap:

inquiry form
contact us
Back to top
Search
inquiry form
contact us